Biologic for renal cancer
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT05287945
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 4, 2023
Completion: Aug 31, 2025
Loading map...